Medtronic valve replacement tops surgery after two years: study

March 15, 2015 5:50 PM

15 0

(Reuters) - Patients treated with Medtronic Plc's CoreValve non-invasive heart valve replacement system fared better two years after the procedure than those who underwent surgical valve replacement, according to data from a study presented on Sunday.

The data not only showed that results seen at one year were sustained a year later, but that there were greater differences favoring Medtronic's transcatheter aortic valve replacement (TAVR) compared with open heart surgery.

Read more

To category page